Pharma & Biotech

Sangamo Therapeutics has announced a series of strategic moves, including detailed clinical trial data and the initiation of a regulatory...

BioAge Labs is set to engage directly with the investment community at a prominent industry event next week. The biotech...

As FutureTech II Acquisition Corp. progresses toward its planned merger with Longevity Biomedical, a recent change in its independent auditing...

The landscape for clinical-stage biotechnology firms is particularly unforgiving at present, placing companies like IO Biotech at a pivotal crossroads....

Capricor Therapeutics is entering a pivotal period in its quest to secure U.S. approval for a treatment targeting Duchenne muscular...

ImmunityBio has achieved a significant regulatory milestone in Europe, securing conditional marketing authorization from the European Commission for its therapy,...

Shares of Ultragenyx Pharmaceutical are navigating a period of significant uncertainty, caught between robust revenue growth and persistent profitability concerns....

Following a successful restructuring of its balance sheet, GRI Bio is now channeling its resources into advancing the clinical programs...

Following its latest quarterly report, Benitec Biopharma is entering a pivotal stage in its corporate evolution. The initial market reaction...

Friday witnessed a dramatic sell-off in Grail's stock, triggered by disappointing news from a major clinical study. While the core...